Integrating patient-relevant outcomes into clinical practice: an interview with Donna Messner


In this podcast, Donna Messner (Center for Medical Technology Policy, MD, USA) shares her insight on some of the challenges and limitations associated with current outcomes measured in clinical trials and the importance of reforming these to be more patient relevant.

 

Clinical trials are the ‘gold standard’, established way of gathering evidence to demonstrate the effectiveness of novel therapeutics, however, there are concerns that endpoints and outcomes assessed in clinical trials do not fully represent those most relevant to patients in everyday clinical practice.

What are some of the challenges and limitations associated with current outcomes measured in clinical trials? What is the importance of reforming these to be more patient relevant? What are some of the current barriers towards adoption of patient-relevant outcomes?

In this latest podcast, we speak with Donna Messner (Center for Medical Technology Policy, MD, USA) to gain her expert insight on these critical questions and more!

Disclosure:

The opinions expressed in this feature are those of the interviewee/author and do not necessarily reflect the views of The Evidence Base® or Future Science Group.